Botanical Solution Inc.
Botanical Solution Inc. (BSI), a Delaware Corporation, has a proprietary R&D platform for truly sustainable and improved production of consistent and high- quality Advanced Botanical Materials (ABM). ABM-01 is the first ABM produced by the company, based on a tissue cultured plant called Quillaja saponaria. ABM-01 is the active ingredient used in two gold standard products, BSI’s biopesticide Quillibrium® and the adjuvant QS-21, used in modern vaccine development.
Latest News
Europe
ADAMA Introduces New Cereal Herbicide in Poland
EDAPTIS is also expected to be registered in multiple...
ABG Update Feature
Industry Insights: ADAMA CEO Steve Hawkins on Managing Overstock, Improving Cash Flow in 2024
ADAMA's Steve Hawkins shares how the company is strategizing...
ABG Update Feature
Intel on New Crop Protection and Adjuvant Opportunities Revealed at CPDA Conference 2024
One of the top opportunities is for companies to...
ABG Update Feature
Kynetec: What’s Driving the Brazilian Biologicals Market
Kynetec’s André Dias recently shared exclusive insights in his...